John Hohneker

CIK: 0001695378

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CRIS

CURIS INC

Director

AVBP

ArriVent BioPharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CRIS
CURIS INC
Jul 7, 2026
Award(A)
Non Qualified Stock Option
Direct
6.8K shares at avg. $5.29-
AVBP
ArriVent BioPharma, Inc.
Jun 18, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
13.6K shares-
AVBP
ArriVent BioPharma, Inc.
Jun 18, 2025
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
15.5K shares-
CRIS
CURIS INC
May 20, 2025
Award(A)
Non Qualified Stock Option
Direct
14.4K shares at avg. $3.13-
CRIS
CURIS INC
Jan 28, 2025
Award(A)
Non Qualified Stock Option
Direct
1.6K shares at avg. $3.13-

		Type	Shares	Price		Ownership
Jul 7, 2026	CRIS CURIS INC	Award(A) Non Qualified Stock Option	6,800	$5.29	-	Direct
Jun 18, 2026	AVBP ArriVent BioPharma, Inc.	Award(A) Non-Qualified Stock Option (right to buy)	13,562	-	-	Direct
Jun 18, 2025	AVBP ArriVent BioPharma, Inc.	Award(A) Non-Qualified Stock Option (right to buy)	15,502	-	-	Direct
May 20, 2025	CRIS CURIS INC	Award(A) Non Qualified Stock Option	14,400	$3.13	-	Direct
Jan 28, 2025	CRIS CURIS INC	Award(A) Non Qualified Stock Option	1,600	$3.13	-	Direct

1-5 of 5 transactions

About Hohneker John

Hohneker John (SEC CIK 0001695378) files insider reports with the SEC as Director of CURIS INC (CRIS) and Director of ArriVent BioPharma, Inc. (AVBP).

Signal8 holds 5 ownership filings by Hohneker John, all Form 4s, filed between Jan 30, 2025 and Jul 9, 2026. Those filings report 5 transactions, from Jan 28, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hohneker John's filings is in LEXINGTON, MA.

Recent filings by Hohneker John

Jul 7, 2026: Grant or award of CRIS derivative securities (Form 4, code A).
Jun 18, 2026: Grant or award of AVBP derivative securities (Form 4, code A).
Jun 18, 2025: Grant or award of AVBP derivative securities (Form 4, code A).
May 20, 2025: Grant or award of CRIS derivative securities (Form 4, code A).
Jan 28, 2025: Grant or award of CRIS derivative securities (Form 4, code A).

Other insiders filing for CURIS INC (CRIS)

How to read Form 4 transaction codes